Epigenetic signature of differentially methylated genes in cutaneous melanoma

Dimitrius T. Pramio1, André Yoshiaki Kashiwabara2, Paula Comune Pennacchi3, Maria Prates Rivas4, Silvya Stuchi Maria-Engler3, Antônio Hugo José Fróes Marques Campos5, João Pedreira Duprat6, Dirce Maria Carraro1, Ana Cristina Victorino Krepischi4
1International Research Center, AC Camargo Cancer Center, São Paulo, SP, Brazil
2Informatics Department, Universidade Tecnológica Federal do Paraná, Cornélio Procópio, PR, Brazil
3Clinical Chemistry and Toxicology Department, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, Brazil
4Department of Genetics and Evolutionary Biology, Institute of Biosciences, University of São Paulo, São Paulo, SP, Brazil
5Department of Anatomic Pathology, AC Camargo Cancer Center, São Paulo, SP, Brazil
6Skin Cancer Department, AC Camargo Cancer Center, São Paulo (SP), Brazil.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002;16:6–21. doi: 10.1101/gad.947102 .

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29. doi: 10.3322/caac.21254 .

Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011;364:2507–16. doi: 10.1056/NEJMoa1103782 .

Tanemura A, Terando AM, Sim M-S, van Hoesel AQ, de Maat MFG, Morton DL, et al. CpG island methylator phenotype predicts progression of malignant melanoma. Clin Cancer Res. 2009;15:1801–7. doi: 10.1158/1078-0432.CCR-08-1361 .

Mori T, O’Day SJ, Umetani N, Martinez SR, Kitago M, Koyanagi K, et al. Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy. J Clin Oncol. 2005;23:9351–8. doi: 10.1200/JCO.2005.02.9876 .

Hou P, Liu D, Dong J, Xing M. The BRAF(V600E) causes widespread alterations in gene methylation in the genome of melanoma cells. Cell Cycle. 2012;11:286–95. doi: 10.4161/cc.11.2.18707 .

Pramio DT, Pennacchi PC, Maria-Engler SS, Campos AHJFM, Duprat JP, Carraro DM, et al. LINE-1 hypomethylation and mutational status in cutaneous melanomas. J Investig Med. 2016;64:899–904. doi: 10.1136/jim-2016-000066 .

Pennacchi PC, de Almeida MES, Gomes OLA, Faião-Flores F, de Araújo Crepaldi MC, Dos Santos MF, et al. Glycated reconstructed human skin as a platform to study the pathogenesis of skin aging. Tissue Eng Part A. 2015;21:2417–25. doi: 10.1089/ten.TEA.2015.0009 .

Brohem CA, da Silva Cardeal LB, Tiago M, Soengas MS, de Moraes Barros SB, Maria-Engler SS. Artificial skin in perspective: concepts and applications. Pigment Cell Melanoma Res. 2011;24:35–50. doi: 10.1111/j.1755-148X.2010.00786.x .

Teschendorff AE, Marabita F, Lechner M, Bartlett T, Tegner J, Gomez-Cabrero D, et al. A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics. 2013;29:189–96. doi: 10.1093/bioinformatics/bts680 .

Wang J, Duncan D, Shi Z, Zhang B. WEB-based GEne SeT AnaLysis toolkit (WebGestalt): update 2013. Nucleic Acids Res. 2013;41:W77–83. doi: 10.1093/nar/gkt439 .

Nik-Zainal S, Van Loo P, Wedge DC, Alexandrov LB, Greenman CD, Lau KW, et al. The life history of 21 breast cancers. Cell. 2012;149:994–1007. doi: 10.1016/j.cell.2012.04.023 .

Ferrarelli LK. Melanoma cells talk to keratinocytes. Science. 2017;355(6330):1169–71. doi: 10.1126/science.355.6330.1169-q .

Ostalecki C, Lee JH, Dindorf J, Collenburg L, Schierer S, Simon B, et al. Multiepitope tissue analysis reveals SPPL3-mediated ADAM10 activation as a key step in the transformation of melanocytes. Sci Signal. 2017;10(470) doi: 10.1126/scisignal.aai8288 .

Liu D, Liu X, Xing M. Epigenetic genes regulated by the BRAFV600E signaling are associated with alterations in the methylation and expression of tumor suppressor genes and patient survival in melanoma. Biochem Biophys Res Commun. 2012;425:45–50. doi: 10.1016/j.bbrc.2012.07.046 .

Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat J-P, et al. A landscape of driver mutations in melanoma. Cell. 2012;150:251–63. doi: 10.1016/j.cell.2012.06.024 .

Akbani R, Akdemir KC, Aksoy BA, Albert M, Ally A, Amin SB, et al. Genomic classification of cutaneous melanoma. Cell. 2015;161:1681–96. doi: 10.1016/j.cell.2015.05.044 .

Conway K, Edmiston SN, Khondker ZS, Groben PA, Zhou X, Chu H, et al. DNA-methylation profiling distinguishes malignant melanomas from benign nevi. Pigment Cell Melanoma Res. 2011;24:352–60. doi: 10.1111/j.1755-148X.2011.00828.x .

Lauss M, Haq R, Cirenajwis H, Phung B, Harbst K, Staaf J, et al. Genome-wide DNA methylation analysis in melanoma reveals the importance of CpG methylation in MITF regulation HHS public access. J Invest Dermatol. 2015;135:1820–8. doi: 10.1038/jid.2015.61 .

Thomas NE. Slater N a. Zhou X, Kuan P-F, Groben P a, et al. DNA-methylation Profiles in Primary Cutaneous Melanomas are Associated with Clinically Significant Pathologic Features. Pigment Cell Melanoma Res: Edmiston SN; 2014. doi: 10.1111/pcmr.12289 .

Ikeda H, Lethé B, Lehmann F, van Baren N, Baurain JF, de Smet C, et al. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity. 1997;6:199–208.

DeYoung KL, Ray ME, Su YA, Anzick SL, Johnstone RW, Trapani JA, et al. Cloning a novel member of the human interferon-inducible gene family associated with control of tumorigenicity in a model of human melanoma. Oncogene. 1997;15:453–7. doi: 10.1038/sj.onc.1201206 .

Haase-Kohn C, Wolf S, Lenk J, Pietzsch J. Copper-mediated cross-linking of S100A4, but not of S100A2, results in proinflammatory effects in melanoma cells. Biochem Biophys Res Commun. 2011;413:494–8. doi: 10.1016/j.bbrc.2011.08.132 .

Miller AJ, Du J, Rowan S, Hershey CL, Widlund HR, Fisher DE. Transcriptional regulation of the melanoma prognostic marker melastatin (TRPM1) by MITF in melanocytes and melanoma. Cancer Res. 2004;64:509–16.

Gao L, van den Hurk K, Moerkerk PTM, Goeman JJ, Beck S, Gruis NA, et al. Promoter CpG Island Hypermethylation in dysplastic nevus and melanoma: CLDN11 as an epigenetic biomarker for malignancy. J Invest Dermatol. 2014;134:2957–66. doi: 10.1038/jid.2014.270 .